DRKS00021532招募中不适用
HCV in patients with addiction study - HIPA study
St. Josefs Hospital Wiesbaden0 个研究点目标入组 1,000 人开始时间: 2021年3月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients with addiction
- •18 years of age or older at the start of the observation
- •Informed consent form signed: no=stop / yes
排除标准
- •informed consent not available
研究者
相似试验
已完成
不适用
Prospective cohort study of HCV infection and the risk of developement of maligant lymphomahematopoietic malignancyJPRN-UMIN000003652Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)2,000
已完成
不适用
Puglia HCV Micro-elimination ProgramHepatitis CNCT03923595Alessandra Mangia231
已完成
4 期
A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus InfectionHepatitis C, ChronicNCT02498015Kirby Institute87
进行中（未招募）
不适用
Chronic hepatitis C in illicit drug users and the role of antiviral therapy: the ARNICA project (Antiviral tReatment for chroNichepatItis C in Active substance users) - ARNICAEUCTR2008-001283-37-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
进行中（未招募）
不适用
HCV/HIV Coinfection- STUDY: MULTICENTER STUDY TO EVALUATE THE EFFICACY OF 48 WEEKS COMBINATION-THERAPY WITH PEGYLATED INTERFERON ALFA 2A (PEG-IFN ALFA 2A) AND DIFFERENT DOSES OF RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C AND HIV -COINFECTION - HIVCopegHIV/HCV - CoinfectionEUCTR2004-004848-45-ATMedizinische Universität Wien80